Companies / Oric Pharmaceuticals, Inc. / Activity

Activity — Oric Pharmaceuticals, Inc.

16 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 24, 2026Piscitelli Dominic
Executive
SellCommon Stock$702.7K-52K
-43.28%
68,148
0.07% of shares
medium
Feb 24, 2026Piscitelli Dominic
Executive
ExerciseCommon Stock$226.7K+52K
+76.30%
120,148
0.12% of shares
low
Jan 16, 2026Heyman Richard A.
Director
SellCommon Stock$42.0K-4K
-7.73%
41,800
0.04% of shares
low
Jan 16, 2026Heyman Richard A.
Director
SellCommon Stock$38.4K-3K
-1.48%
213,072
0.21% of shares
low
Feb 24, 2026Piscitelli Dominic
Executive
ExerciseStock Option (right to buy)—-52K
-26.46%
144,500
0.14% of shares
low
Jan 2, 2026Piscitelli Dominic
Executive
GrantRestricted Stock Unit—+35K
34,500
0.03% of shares
low
Jan 2, 2026Piscitelli Dominic
Executive
GrantStock Option (right to buy)—+207K
206,500
0.20% of shares
low
Jan 2, 2026You Angie
Director
GrantStock Option (right to buy)—+40K
40,000
0.04% of shares
low
Jan 2, 2026Chacko Jacob
CEO
GrantRestricted Stock Unit—+113K
112,500
0.11% of shares
low
Jan 2, 2026Chacko Jacob
CEO
GrantStock Option (right to buy)—+675K
675,000
0.65% of shares
low
Jan 2, 2026Multani Pratik S
Executive
GrantRestricted Stock Unit—+36K
35,500
0.03% of shares
low
Jan 2, 2026Multani Pratik S
Executive
GrantStock Option (right to buy)—+214K
214,000
0.21% of shares
low
Jan 2, 2026Heyman Richard A.
Director
GrantStock Option (right to buy)—+40K
40,000
0.04% of shares
low
Jan 2, 2026Dier Mardi
Director
GrantStock Option (right to buy)—+40K
40,000
0.04% of shares
low
Jan 2, 2026Kunkel Lori Anne
Director
GrantStock Option (right to buy)—+40K
40,000
0.04% of shares
low
Jan 2, 2026Hoerter Steven L.
Director
GrantStock Option (right to buy)—+40K
40,000
0.04% of shares
low
← PrevPage 1 of 1Next →